Get the content you want anytime you want.

Healthcare professionals and thought leaders share their knowledge and insights on an array of infectious disease topics

Latest Videos

Zerbaxa and Avycaz: Considerations for Treatment
Panelists identify, in light of the available guidelines and data, the rationale behind and optimal use of currently approved cephalosporin/β-lactamase inhibitor combinations.
Is There A Link Between Lyme Disease and Chronic Fatigue Syndrome?
Samuel, Shor, MD, FACP, discusses the potential link between chronic fatigue syndrome and Lyme disease.
Cost Considerations of IV Antibiotics for ABSSSI
Panelists consider and discuss the costs of acute bacterial skin and skin structure infections patient hospital admissions, extended lengths of stay, and IV antibiotic protocol and reimbursements.
Current Treatments for MDR Bacteria and Their Drawbacks
Jason Gallagher, PharmD, provides an overview of the current treatment options for multidrug-resistant bacteria, including gaps in their therapy and safety concerns.
Multidrug-Resistant Bacterial Infections: Key Messages
Peter L. Salgo, MD; Andrew Shorr, MD; Debra Goff, PharmD, FCCP; Sandy J. Estrada Lopez, PharmD, BCPS (AQID); and Jason Pogue, PharmD, BCPS-AQID, close their discussion by highlighting take-home messages and emphasizing the importance of healthcare provider hygiene, not just for multidrug-resistant bacterial infections but in all settings.
ABSSSI: Standard Protocol of Admission and Treatment
Panelists share the typical presentation of an acute bacterial skin and skin structure infection patient in the emergency department and the standard protocol of IV antibiotics.
Using Prediction Scores to Guide Empiric Therapy
Julie Ann Justo, PharmD, MS, BCPS-AQ ID, discusses how prediction scores are used to guide empiric therapy.
Why Are Health Care Providers Using Fluoroquinolones Despite the FDA Warning?
Barbara Wells Trautner, MD, PhD, discusses why physicians are using fluoroquinolones despite the FDA’s warning.
Big advances in treatment can